In a recent clinical trial, researchers Vicki Anderson et al. assessed a symptom-targeted multidisciplinary treatment for persisting post-concussion symptoms in youth.

For adults who presented with a concussion at the emergency department (ED) at a level 1 trauma center, certain characteristics and symptoms were significantly associated with an increased risk of persisting symptoms after concussion (PSaC) at one month post-injury.

Both The Washington Post and The New York Times recently published articles about how GLP-1 medications (GLP-1s), approved for diabetes and weight loss, have a wider range of benefits for the body than previously thought, including potential benefits to the brain.